81
39
Growth Score 81 in past quarter
-4 pts
Heat Score 39 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
805051
Squarex is a clinical-stage pharmaceutical company developing a drug and topical application to prevent infections.
- Hugh McTavish: Co-Founder & President
- Thomas D. Horn: Co-Founder
About the Company
Squarex is a clinical-stage pharmaceutical company developing a drug and topical application to prevent infections. This application develops a topical formulation of the immunomodulator squaric acid dibutyl ester for the prevention of recurrent cold sores and other infections caused by Herpes Simplex Virus 1 or Herpes Simplex Virus 2.
The company
was founded in 2012 and is headquartered in Saint Paul, Minnesota.